Latest:

Fat Pitch Financials

Special situation stocks and value investing

Stock Quote

Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
INFINITY PHRMA RG (NQ: INFI)
2.030 USD  -0.015 (-0.73%)
Official Closing Price  /  Updated: 8:00 PM EDT, May 25, 2018  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 288,858
Open 2.060
Bid (Size) 1.950 (1000)
Ask (Size) 2.060 (5000)
Prev. Close 2.045
Today's Range 1.990 - 2.060
52wk Range 0.9255 - 3.750
Shares Outstanding 56,069,632
Dividend Yield N/A
Performance
YTD
-8.97%
-8.97%
1 Month
-6.02%
-6.02%
3 Month
+9.73%
+9.73%
6 Month
-0.49%
-0.49%
1 Year
+16.67%
+16.67%
Top News
More News
Infinity Announces Presentations On IPI-549 At Upcoming American Society of Clinical Oncology Annual Meeting
- Company to Host Investor Reception and Webcast on June 4, 2018, at 6:30 a.m. CT - Read More
from PR Newswire
Infinity Pharmaceuticals Provides Company Update and First Quarter 2018 Financial Results
-- Company to Present Data from Combination Dose Escalation Component of Study at American Society of Clinical Oncology Annual Meeting (ASCO) -- Read More
from PR Newswire
More News
Read More
Infinity Announces The Date Of Its First Quarter 2018 Financial Results Conference Call And Webcast
from PR Newswire
Serametrix MDSC Assay Being Utilized By Infinity Pharmaceuticals in the First Clinical Study to Prospectively Identify Patients With High Blood Levels of MDSCs
from Business Wire News Releases
Infinity to Present at Two Upcoming Conferences
from PR Newswire
Infinity To Present At BioCentury's 25th Annual Future Leaders In The Biotech Industry Conference
from PR Newswire
Infinity Pharmaceuticals Provides Company Update and Reports Fourth Quarter and Full Year 2017 Financial Results
from PR Newswire
Infinity Announces the Date of Its Fourth Quarter and Full Year 2017 Financial Results Conference Call and Webcast
from PR Newswire
Infinity Pharmaceuticals Announces Additions to Board of Directors and Clinical Leadership Team and Establishes Scientific Advisory Board
from PR Newswire
BRIEF-Infinity Pharmaceuticals Q1 Loss Per Share $0.18
category companyNews
from Reuters: Company News
Sum Up The Pieces: VFQY Could Be Worth $92
category ETFs
from ETF Channel
Stock Market JSON API provided by www.cloudquote.net
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial